A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19), emerged in Wuhan, China, and rapidly spread across the world. Today, we present an interesting case of a patient with no prior history of pulmonary disease who was diagnosed with COVID-19, recovered after a prolonged hospital course, and was diagnosed with pulmonary fibrosis requiring oxygen therapy thereafter. The patient is currently on pirfenidone and has had a significant improvement in his functional status. His oxygen requirements have decreased, and repeat computed tomography (CT) scanning has demonstrated improvement in the extent of his pulmonary fibrosis. This case highlights the possibility of pulmonary fibrosis being a major complication among COVID-19 survivors and the importance of using pirfenidone in the management of such cases.
【저자키워드】 COVID-19, pulmonary fibrosis, COVID, Respiratory disease, pulmonary disease, pulmonary critical care, medical icu, fibrotic lung disease, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, hospital, Novel coronavirus, Spread, Computed tomography, management, Patient, Oxygen therapy, acute respiratory syndrome, Oxygen requirement, survivor, highlight, Wuhan, China, Course, diagnosed, functional, demonstrated, diagnosed with COVID-19, 【제목키워드】 pulmonary,